XM does not provide services to residents of the United States of America.
A
A

Antofagasta

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Antofagasta jumps on $1.5 bln investment deal

BUZZ-Antofagasta jumps on $1.5 bln investment deal ** London-listed shares of Chilean miner Antofagasta ANTO.L jump 2.4% to 2,202 pence ** Shares top gainer on FTSE 100 .FTSE index which is up 0.1% ** Co on Wednesday signed a $1.5 bln investment deal to improve water supply at its Chile mining ops ** Deal is to set up a water transportation system
A
U

Antofagasta signs $1.5 bln investment deal for water transport system in Chile mine

UPDATE 1-Antofagasta signs $1.5 bln investment deal for water transport system in Chile mine Updates with deal details in paragraphs 1-3 June 5 (Reuters) - London-listed Antofagasta ANTO.L on Wednesday signed a $1.5 billion investment deal to improve water supply at its Chile mining operations. The deal, signed with a firm owned by Madrid-based Almar Water Solutions and Chile-based power transmission company Transelec, is to set up a water transportation system that will provide non-desalinated
A
A

Antofagasta to invest $1.5 bln for water transport system in Chile copper mine

Antofagasta to invest $1.5 bln for water transport system in Chile copper mine June 5 (Reuters) - London-listed Antofagasta ANTO.L on Wednesday signed a $1.5 billion investment for a water transportation system with a firm owned by Madrid-based Almar Water Solutions and Chile-based power transmission company Transelec for its Centinela mining operation in Chile.
A
A

4Imprint, AstraZeneca, Bellway

EUROPE RESEARCH ROUNDUP-4Imprint, AstraZeneca, Bellway June 5 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including 4Imprint, AstraZeneca and Bellway, on Wednesday. HIGHLIGHTS * 4Imprint FOUR.L : HSBC raises target price to 6370p from 6060p * AstraZeneca AZN.L : HSBC raises target price to 14070p from 12950p * Bellway Plc BWY.L : Berenberg raises target price to 2900p from 2500p * Berkeley Group BKGH.L : Berenberg raises target price to
A
A
B
B
B
B
B
C
E
G
G
H
H
I
M
M
O
P
R
R
S
B
E
M
N
P
R
S
T

Currys, Ovhcloud, Whitbread

EUROPE RESEARCH ROUNDUP-Currys, Ovhcloud, Whitbread May 30 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Currys, Ovhcloud and Whitbread, on Thursday. HIGHLIGHTS * Anglo American AAL.L : Jefferies cuts to hold from buy * Currys Plc CURY.L : Berenberg raises to buy from hold * Ovhcloud OVH.PA : Stifel cuts to hold from buy * Solvay SOLB.BR : Morgan Stanley raises to equal weight from underweight * Whitbread WTB.L : Berenberg cuts t
A
A
B
B
E
F
G
K
L
L
M
M
N
P
R
S
W
W
H
A
A
A
M

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.